Blockchain Registration Transaction Record

Bio-Path Holdings Advances RNAi Therapeutics with DNAbilize® Platform

Bio-Path Holdings innovates with DNAbilize® platform, advancing RNAi therapeutics for cancer and metabolic diseases, offering new hope for patients.

Bio-Path Holdings Advances RNAi Therapeutics with DNAbilize® Platform

The advancements by Bio-Path Holdings in RNAi therapeutics could revolutionize the treatment of cancer and metabolic diseases, offering hope to patients with limited options. The company's innovative DNAbilize® platform addresses key challenges in drug delivery, potentially leading to more effective and safer treatments. This news is crucial for investors, healthcare professionals, and patients alike, as it highlights the potential for groundbreaking therapies in the near future.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0xa4c07957c06bf0d8ba8bee449c5472de8f5ddaf1e3d2ff8e61173902cc221c45
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintlofttAbn-1f4f1bf4a382dd82725652205efd7137